Testing effectiveness (Phase 2)Study completedNCT00942734
What this trial is testing
Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma
Who this might be right for
Head And Neck Cancer
M.D. Anderson Cancer Center 49
Showing 20 of 0 results